Business / Finance

RSS

Meridian Bioscience first quarter net sales increase 8% to $40.3 million

Meridian Bioscience, Inc., Cincinnati, Ohio today: reported first quarter net sales of $40.3 million, an increase of 8% from the same period of the prior fiscal year.

25 Jan 2012

Prosensa secures €23M in new equity financing

Prosensa, the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet needs, announced today that it has raised €23 million in new equity financing.

25 Jan 2012

Roche proposes to acquire Illumina for $44.50 per share

Roche announced today that it is proposing to acquire all outstanding shares of Illumina, Inc. for $44.50 per share in cash, or an aggregate of approximately $5.7 billion on a fully diluted basis.

From Roche Sequencing and Life Science 24 Jan 2012

Johnson & Johnson fourth quarter sales increase 3.9% to $16.3 billion

Johnson & Johnson today announced sales of $16.3 billion for the fourth quarter of 2011, an increase of 3.9% as compared to the fourth quarter of 2010. Operational sales increased 4.0% and the negative impact of currency was 0.1%.

24 Jan 2012

OSI Systems' second quarter revenues increase 11% to $188 million

OSI Systems, Inc., a vertically integrated provider of solutions in Security, Healthcare, and specialized electronics, today announced financial results for the second quarter ended December 31, 2011.

24 Jan 2012

Aquilent awarded new IT contracts by the HHS

Aquilent, the recognized leading provider of Web-based solutions shaping the next generation of technology for the federal government, today announced it has been awarded more than a dozen new contracts within the past several months supporting numerous operating divisions and programs within the U.S. Department of Health and Human Services (HHS).

24 Jan 2012

UCSD receives approval to acquire NVCI

UC San Diego Health System has received approval to acquire the Nevada Cancer Institute (NVCI), the official cancer institute of the state of Nevada, as an affiliate health care provider. The expansion represents a partnership between California and Nevada in offering lifesaving cancer care to patients through expert diagnosis, novel treatments and clinical trials.

24 Jan 2012

Fitbit raises $12 Million in Series C funding

Fitbit, the market leader in the digital health and fitness device category and maker of the popular Fitbit Ultra Wireless Activity and Sleep Tracker, today announced it raised $12 Million in Series C funding from existing investors: Foundry Group, True Ventures, SoftTech VC and Felicis Ventures. The capital will be used to further accelerate the company's strong growth trajectory.

24 Jan 2012

Pernix obtains marketing rights to new gastroenterology product in the U.S.

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, today announced it has entered into a license and supply agreement with a private company for a new FDA-approved prescription product to treat gastroenterology disease.

24 Jan 2012

Watson announces acquisition of Ascent Pharmahealth

Watson Pharmaceuticals, Inc. announced that it has acquired Ascent Pharmahealth Ltd, the Australia and Southeast Asia generic pharmaceutical business of Strides Arcolab Ltd, for AU$375 million in cash.

24 Jan 2012

EntreMed announces $10 million in financing from strategic accredited investors

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has secured $10 million in financing with strategic accredited investors, including IDG-Accel China Growth Fund II L.P., Emerging Technology Partners, LLC, and Dr. Tak W. Mak, Director of The Campbell Family Institute for Cancer Research.

23 Jan 2012

TONIX receives net proceeds of $1.9M in private placement

TONIX Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, has received net proceeds of approximately $1.9 million in a private placement offering to institutional and accredited investors.

23 Jan 2012

VisionCare closes expansion of Series E financing

VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of end-stage age-related macular degeneration (AMD), today announced the closing of expansion of the Series E financing, with Agate Medical Investments leading the expansion round. Agate's Managing General Partner, Chanan Schneider, will join the VisionCare team as a board observer.

23 Jan 2012

UnitedHealth's profits rise

The company reported that its fourth-quarter profits rose 21 percent, driving by increases in health-insurance membership and continued light health care usage.

21 Jan 2012

Sequenom prices underwritten public offering of 13,000,000 shares of common stock

Sequenom, Inc. today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock, offered at a price to the public of $4.15 per share.

20 Jan 2012

TCRH forms new joint venture with Duke LifePoint

Twin County Regional Healthcare (TCRH) has entered into a new agreement that will secure the hospital's position as a trusted provider of quality healthcare services for years to come. The TCRH Board of Directors and Duke LifePoint Healthcare today announced they have signed a definitive agreement to jointly own and operate Twin County Regional Healthcare and its affiliated assets.

20 Jan 2012

Kronos acquires assets of OptiLink

Kronos Incorporated today announced that it has acquired the assets of OptiLink from The Advisory Board Company in a cash transaction. As a result of the acquisition, Kronos has added one of the industry's leading acuity-based staffing solutions to its healthcare workforce management suite. Kronos now offers the most advanced, clinically-focused workforce management suite designed to help healthcare organizations deliver high-quality patient care.

20 Jan 2012

GE fourth-quarter total revenues increase 4% to $38.0 billion

GE announced today fourth-quarter 2011 Operating Earnings of $4.1 billion, or $0.39 per share, up 6% and 11% respectively from the fourth-quarter of 2010. Revenues were $38.0 billion for the quarter and $147.3 billion for the year. Record Infrastructure orders of $28.6 billion in the fourth quarter enabled GE to end the year with a backlog of $200 billion, the largest in its history.

20 Jan 2012

PolyTherics announces acquisition of WEP

PolyTherics Limited, a provider of solutions to biopharmaceutical companies for the improvement of protein and peptide based drugs, is pleased to announce the acquisition of Warwick Effect Polymers, a provider of specialty biopolymers for the modification of biological products.

20 Jan 2012

FDA, pharmaceutical industry reach agreement on user-fee plan for generics

The Food and Drug Administration would collect hundreds of millions of dollars in new fees from pharmaceutical companies to help speed up the review of generic drugs, under an agreement with the industry released by the agency on Friday.

19 Jan 2012